| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/27/2008 | WO2008034908A2 Use of vitamin d compounds for the prevention of adhesions |
| 03/27/2008 | WO2008034316A1 Compound preparation capable of reducing oxidative stress rapidly and the preparative method thereof |
| 03/27/2008 | WO2008034176A1 Cross-linked polysaccharide gels |
| 03/27/2008 | WO2008002674A3 Bicyclic compositions and methods for modulating a kinase cascade |
| 03/27/2008 | US20080077372 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 03/27/2008 | US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/27/2008 | US20080076836 Method and apparatus for using light to enhance cell growth and survival |
| 03/27/2008 | US20080076817 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases |
| 03/27/2008 | US20080076815 Sulfonamide or sulfonimide functional indazole or indole compounds such as N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydryoxyethyl]phenyl]methanesulfonamide; diabetes, obesity, hyperlipidemia and urinary incontinence |
| 03/27/2008 | US20080076803 Antimicrobial preservative comprising a mixture of 1,2-benzisothiazolin-3-one, pyrithione or salts thereof, and an alkalinizing agent to bring the pH to 11 or higher; free of ethylenediamine and N-alkylisothiazolin-3-one; water solubility; high stability at various temperatures, clear concentrates |
| 03/27/2008 | US20080076796 Methods and Compositions for the Treatment of Alcoholism and Alcohol Dependence |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076784 Bicyclic, Nitrogen-Containing Heterocycles and Aromatase Inhibitors |
| 03/27/2008 | US20080076782 Sodium channel blockers |
| 03/27/2008 | US20080076781 Pseudobase benzo[c]phenanthridines with improved efficacy, stability, and safety |
| 03/27/2008 | US20080076776 Therapeutic compounds |
| 03/27/2008 | US20080076774 Kinase Modulators and Methods of Use |
| 03/27/2008 | US20080076770 -[4-(4,5-dichloro-1H-imidazol-1-yl)-phenyl]-3-(4-trifluoromethyl-phenyl)-urea; useful for treating hypertensive, cardiovascular, inflammatory, and diabetes related diseases |
| 03/27/2008 | US20080076764 HPTPbeta as a target in treatment of angiogenesis mediated disorders |
| 03/27/2008 | US20080076759 Therapeutic Heterocyclic Compounds 507 |
| 03/27/2008 | US20080076749 Stabilizing compositions for antibiotics and methods of use |
| 03/27/2008 | US20080076737 Drug design for tubulin inhibitors, compositions, and methods of treatment thereof |
| 03/27/2008 | US20080076736 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
| 03/27/2008 | US20080076732 Gene expression control DNA element and associated protein |
| 03/27/2008 | US20080076729 antiinflammatory; cystic fibrosis; |
| 03/27/2008 | US20080076728 Novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 03/27/2008 | US20080076727 antibody cocktails each recognizing a distinct epitope on the HMW-MAA protein; |
| 03/27/2008 | US20080076719 oligopeptides derived from human chorionic gonadotropin (hCG); compositions exhibiting immunoregulatory activity as determined by measuring the compound's ability to modulate production of NO by a cell |
| 03/27/2008 | US20080076712 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/27/2008 | US20080076710 covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides treating Hepatitis-C virus |
| 03/27/2008 | US20080076708 Active Variants of the Il-18 Binding Protein and Medical Uses Thereof |
| 03/27/2008 | US20080076706 stimulate proliferation and differentiation of hematopoietic cells in animal, by administering an isolated PEGylated granulocyte colony stimulating factor comprising a cysteine variants; drugs/polymer conjugates/; bone marrow transplantation, infection with the human immunodeficiency virus, neutropenia |
| 03/27/2008 | US20080076701 double stranded ribonucleic acid is conjugated to the peptide; interfering ribonucleic acid with a delivery peptide; biodrug treating influenza in animal, inflammation occurs in arthritis, psoriasis |
| 03/27/2008 | US20080075794 Natural antimicrobial and method of manufacturing the same |
| 03/27/2008 | US20080075785 Controlled release hydrogel formulation |
| 03/27/2008 | US20080075782 Comprising a stabilizing polyol and a bioactive agent, wherein the composition provides quick release of the bioactive agent after administration; inhalation through the mouth; drug delivery; osteoporosis treatment |
| 03/27/2008 | US20080075773 Solid oral composition comprising 3-(5-methoxy-1H-indol-3-yl-methylene)-N-pentylcarbazimidamide or salt and disintegrant comprising crospovidone, sodium starch glycolate, carboxymethylcellulose sodium, sodium alginate; for administering active agents which are poorly soluble in water or acid sensitive |
| 03/27/2008 | US20080075769 Psychostimulant containing pharmaceutical composition |
| 03/27/2008 | US20080075763 Polycationic sterol derivatives as transfection agents |
| 03/27/2008 | US20080075749 Methods and Compositions for Tissue Augmentation |
| 03/27/2008 | US20080075744 Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine |
| 03/27/2008 | US20080075740 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 03/27/2008 | US20080075739 Attenuated Salmonella SP12 Mutants as Antigen Carriers |
| 03/27/2008 | US20080075733 receptor for advanced glycosylation end products polypeptide directly linked to a polypeptide comprising a CH2 domain of an immunoglobulin; biodrug for treating amyloidosis, Alzheimer's disease, cancer, autoimmune disease, inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis |
| 03/27/2008 | US20080075732 Preparation of Antigen-Presenting Human Gamma-Delta T Cells and Use in Immunotherapy |
| 03/27/2008 | US20080075730 Methods and compositions for treating biofilms |
| 03/27/2008 | US20080075729 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents |
| 03/27/2008 | US20080075727 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/27/2008 | US20080075723 Endotheliase 2 ligands |
| 03/27/2008 | US20080075722 detecting the presence of a protein marker in patient sample, using a reagent which specifically binds with protein; comparing the copy number of a minimal common region; anticarcinogenic biodrugs |
| 03/27/2008 | US20080075719 Method for Augmenting B Cell Depletion |
| 03/27/2008 | US20080075715 modified polypeptides, whereby the modification results in a reduced number of potential lymphocyte epitopes that provides a reduced propensity for the polypeptide to elicit an immune response upon administration to a human, but retain the ability to bind to CD52 antigens |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |
| 03/27/2008 | US20080075710 Herbal composition for treating hangovers |
| 03/27/2008 | US20080075706 Pharmaceutical formulation |
| 03/27/2008 | US20080075704 Time varying electromagnetic force ("TVEMF") expanded blood stem cells from a mammal, used for repair of tissues |
| 03/27/2008 | US20080075702 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 03/27/2008 | US20080075698 Brain-Localizing Bone Marrow Progenitor cells |
| 03/27/2008 | US20080075694 kits containing genetic engineered modified vaccinia virus ankara (MVA), which carries a nucleotide sequence that codes for a fusion protein, used for enhancing T cell responses in mammals |
| 03/27/2008 | US20080075691 Permucosal Composition and Method of Improving Permucosal Absorption |
| 03/27/2008 | US20080075680 separating plant components, then immersion and culturing in aqueous solutions of sodium chloride and sucrose, separation and diluting in water, fermenting, filtering and supernatants for use nutritientsl, drugs and cosmetics; treatment of alopecia |
| 03/27/2008 | US20080075667 Nanoparticles, nanocapsules and nanogels |
| 03/27/2008 | US20080075662 Novel Method for Analyzing Nucleic Acid Et Use Thereof for Evaluating the Degree of Mrna Editing of the Serotonin 5-Ht2c Receptor |
| 03/27/2008 | US20080075660 Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
| 03/27/2008 | US20080075659 Determining the percentage of monoclonal, chimerized, murine or humanized antibody greater than 90 percent using excess amount of CD66 antigen, and the percentage of immunoreactive antibody that binds specifically to CD66 |
| 03/27/2008 | US20080075658 Adsorbing a radionuclide onto activated charcoal, blending with an insoluble polymer powder and heating; gastrointestinal tract |
| 03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 03/26/2008 | EP1903112A2 Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family |
| 03/26/2008 | EP1903045A1 Pyrazolopyrimidine derivative |
| 03/26/2008 | EP1902732A1 Prophylactic/therapeutic agent for her2-expressing cancer |
| 03/26/2008 | EP1902731A1 Preventive or remedy for glaucoma |
| 03/26/2008 | EP1902729A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
| 03/26/2008 | EP1902716A1 Prophylactic and/or therapeutic agent for motor disorder |
| 03/26/2008 | EP1902714A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 03/26/2008 | EP1902020A1 Derivatives of seleno-amino acids |
| 03/26/2008 | EP1901778A2 Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds |
| 03/26/2008 | EP1901755A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 03/26/2008 | EP1901747A2 Pyrimidine-based cdk inhibitors for treating pain |
| 03/26/2008 | EP1901701A2 Personal care and medicinal products incorporating bound organosulfur groups |
| 03/26/2008 | EP1684775B1 Use of extracts from the pelargonium species |
| 03/26/2008 | EP1490037B1 Taste masked veterinary solid compositions |
| 03/26/2008 | EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 03/26/2008 | EP1458866B1 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 03/26/2008 | EP1455790B1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP1196396B1 Pharmacologically active compounds with two covalently linked active principles (sodium channnel blocker/p2y2 receptor agonist) for the treatment of mucosal surfaces |
| 03/26/2008 | EP0917535B1 Neuroactive peptide |
| 03/26/2008 | CN101151246A 1-benzylindole-2-carboxamide derivatives |
| 03/26/2008 | CN101151050A Agent for control of degranulation reaction and cytokine production |
| 03/26/2008 | CN101151046A Anti-viral agent |
| 03/26/2008 | CN101151045A Methods for suppressing neovascularization using EphrinB2 |
| 03/26/2008 | CN101151039A Inorganic materials for hemostatic modulation and therapeutic wound healing |
| 03/26/2008 | CN101151036A Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same |
| 03/26/2008 | CN101151033A Preventive and/or therapeutic agent for rheumatoid arthritis |
| 03/26/2008 | CN101151032A Pharmaceutical composition and method using antifungal agent in combination |
| 03/26/2008 | CN101147772A Fuming and washing medicine for treating sheath tube stenosis |
| 03/26/2008 | CN101147581A White Chinese sorghum nutritive powder and preparation method thereof |
| 03/26/2008 | CN100376592C Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor |
| 03/26/2008 | CN100376583C Esters in position 20 of camptothecins |
| 03/26/2008 | CN100376581C [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |